...
机译:含有取代的稠合四氢吡喃基四氢呋喃作为P2-配体的HIV-1蛋白酶抑制剂的设计,合成,生物学评估和X射线结构研究
Departments of Chemistry and Medicinal Chemistry, Purdue University, West Lafayette, IN 47907, USA;
Departments of Chemistry and Medicinal Chemistry, Purdue University, West Lafayette, IN 47907, USA;
Departments of Chemistry and Medicinal Chemistry, Purdue University, West Lafayette, IN 47907, USA;
Departments of Chemistry and Medicinal Chemistry, Purdue University, West Lafayette, IN 47907, USA;
Departments of Chemistry and Medicinal Chemistry, Purdue University, West Lafayette, IN 47907, USA;
Department of Biology, Molecular Basis of Disease, Georgia State University, Atlanta, Georgia 30303, USA;
Department of Biology, Molecular Basis of Disease, Georgia State University, Atlanta, Georgia 30303, USA;
Department of Biology, Molecular Basis of Disease, Georgia State University, Atlanta, Georgia 30303, USA;
Kumamoto University School of Medicine, Department of Hematology and Infectious diseases, Kumamoto 860-8556, Japan;
Kumamoto University School of Medicine, Department of Hematology and Infectious diseases, Kumamoto 860-8556, Japan,Experimental Retrovirology Section, HIV and AIDS Malignancy Branch, National Cancer Institute, Bethesda, Maryland 20892, USA;
机译:HIV-1蛋白酶抑制剂与氨基双四氢呋喃衍生物作为P2-配体增强骨架结合相互作用的设计:合成,生物学评估和蛋白质配体X射线研究。
机译:用(s) - 乙酰丁酰胺 - 叔胺 - 乙酰胺作为P2-配体的设计与合成效率HIV-1蛋白酶抑制剂:结构 - 活性研究和生物学评价
机译:以C3-取代的六氢环戊呋喃基氨基甲酸酯为P2-配体的HIV-1蛋白酶抑制剂的设计:合成,生物学评估和蛋白配体X射线晶体结构
机译:新型取代嘌呤作为HIV-1 Tat-TAR抑制剂的设计,合成和生物学评估
机译:新型HIV-1蛋白酶抑制剂的核心结构中间体的设计与合成,新型20S蛋白酶体抑制剂的合成,生物学活性和分子建模。
机译:含取代的四氢吡喃基四氢呋喃为P2-配体的HIV-1蛋白酶抑制剂的设计合成生物学评估和X射线结构研究
机译:灵活的环醚/聚醚作为HIV-1蛋白酶抑制剂的新型p2配体:设计,合成,生物学评价和蛋白质配体X射线研究